Karen Davis
by Karen Davis
by Karen Davis
Reposted by Karen Davis
A lot of factors are at play. Access through the Vaccines for Children program should open up now that the acting CDC director finally approved the CDC vaccine panel's recommendations, but other barriers remain.
by Karen Davis
Reposted by Karen Davis
Reposted by Karen Davis
Reposted by Karen Davis
Reposted by Karen Davis, Stacie B. Dusetzina, Ameet Sarpatwari
White House fact sheet says discounts are off list prices
Pfizer’s Xeljanz list price = $6,073/month
40% discount = $3,643/month
@dusetzinas.bsky.social: “How is this a reasonable cash price?”
by Karen Davis
by Karen Davis
Reposted by Karen Davis
📸 T. Carmack | National Park Service
by Karen Davis
by Karen Davis
by Karen Davis
Reposted by Karen Davis
by Karen Davis
Reposted by Karen Davis
by Karen Davis
Reposted by Karen Davis
by Karen Davis
by Karen Davis
Reposted by Karen Davis
by Karen Davis
by Karen Davis
by Karen Davis
by Karen Davis
by Karen Davis
by Karen Davis
by Karen Davis